药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Propiomazine
Ifosfamide
The metabolism of Ifosfamide can be increased when combined with Sulfinpyrazone.
Propiomazine
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be increased when combined with Sulfinpyrazone.
Propiomazine
Aripiprazole
The metabolism of Aripiprazole can be increased when combined with Sulfinpyrazone.
Propiomazine
Pralsetinib
Pralsetinib may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Propiomazine
Valinomycin
Valinomycin may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Propiomazine
Letermovir
Letermovir may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Propiomazine
Lenvatinib
Lenvatinib may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Propiomazine
Simeprevir
Simeprevir may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Propiomazine
Fusidic acid
Fusidic acid may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Propiomazine
Rivaroxaban
Sulfinpyrazone may increase the anticoagulant activities of Rivaroxaban.
Propiomazine
Pentoxifylline
Pentoxifylline may increase the antiplatelet activities of Sulfinpyrazone.
Propiomazine
Obinutuzumab
The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Obinutuzumab.
Propiomazine
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Sulfinpyrazone.
Propiomazine
Glucosamine
Glucosamine may increase the antiplatelet activities of Sulfinpyrazone.
Propiomazine
Hyodeoxycholic Acid
The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Hyodeoxycholic Acid.
Propiomazine
Dehydrocholic acid
The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Dehydrocholic acid.
Propiomazine
Bamet-UD2
The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Bamet-UD2.
Propiomazine
Tauroursodeoxycholic acid
The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Tauroursodeoxycholic acid.
Propiomazine
Taurochenodeoxycholic acid
The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Taurochenodeoxycholic acid.
Propiomazine
Chenodeoxycholic acid
The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Chenodeoxycholic acid.